Wordt geladen...
Epigenetics in Brain Tumors: HDACs Take Center Stage
Primary tumors of the brain account for 2 % of all cancers with malignant gliomas taking the lion’s share at 70 %. Malignant gliomas (high grade gliomas WHO° III and °IV) belong to one of the most threatening tumor entities known for their disappointingly short median survival time of just 14 months...
Bewaard in:
| Gepubliceerd in: | Curr Neuropharmacol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Bentham Science Publishers
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4787285/ https://ncbi.nlm.nih.gov/pubmed/26521944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X13666151030162457 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|